EC Number | Application | Comment | Organism |
---|---|---|---|
3.4.17.22 | medicine | knocking out CpD gene expression provides one solution to eliminating C-terminal lysine heterogeneity for therapeutic antibody production | Cricetulus griseus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.16.6 | Cricetulus griseus | G3HR95 | - |
- |
3.4.17.22 | Cricetulus griseus | G3HR95 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.16.6 | CHO cell | - |
Cricetulus griseus | - |
3.4.17.22 | CHO cell | - |
Cricetulus griseus | - |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.16.6 | CPD | - |
Cricetulus griseus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.16.6 | physiological function | CpD is the only endogenous carboxypeptidase that cleaves antibody heavy chain C-terminal lysine in CHO cells. Knockdown of CpD by RNAi increases C-terminal lysine levels of antibodies, whereas there is no obvious change in C-terminal lysine levels when carboxypeptidase CpM, CpN, CpB, or CpE is knocked downIn a CpD knockout mutant, C-terminal lysine cleavage is completely abolished | Cricetulus griseus |
3.4.17.22 | physiological function | carboxypeptidase D is the only enzyme responsible for antibody C-terminal lysine cleavage in Chinese Hamster Ovary (CHO) cells | Cricetulus griseus |